How Much Binding Affinity Can be Gained by Filling a Cavity?
Open Access
- 6 January 2010
- journal article
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 75 (2) , 143-151
- https://doi.org/10.1111/j.1747-0285.2009.00921.x
Abstract
Binding affinity optimization is critical during drug development. Here, we evaluate the thermodynamic consequences of filling a binding cavity with functionalities of increasing van der Waals radii (–H, –F, –Cl, and CH3) that improve the geometric fit without participating in hydrogen bonding or other specific interactions. We observe a binding affinity increase of two orders of magnitude. There appears to be three phases in the process. The first phase is associated with the formation of stable van der Waals interactions. This phase is characterized by a gain in binding enthalpy and a loss in binding entropy, attributed to a loss of conformational degrees of freedom. For the specific case presented in this article, the enthalpy gain amounts to −1.5 kcal/mol while the entropic losses amount to +0.9 kcal/mol resulting in a net 3.5‐fold affinity gain. The second phase is characterized by simultaneous enthalpic and entropic gains. This phase improves the binding affinity 25‐fold. The third phase represents the collapse of the trend and is triggered by the introduction of chemical functionalities larger than the binding cavity itself [CH(CH3)2]. It is characterized by large enthalpy and affinity losses. The thermodynamic signatures associated with each phase provide guidelines for lead optimization.Keywords
This publication has 43 references indexed in Scilit:
- Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosisJournal of Medicinal Chemistry, 2006
- The interpretation of protein structures: Estimation of static accessibilityPublished by Elsevier ,2004
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- The Binding Energetics of First- and Second-Generation HIV-1 Protease Inhibitors: Implications for Drug DesignArchives of Biochemistry and Biophysics, 2001
- Shape and energetics of a cavity in c-Myb probed by natural and non-natural amino acid mutationsJournal of Molecular Biology, 1999
- The structural stability of the HIV-1 protease 1 1Edited by P. E. WrightJournal of Molecular Biology, 1998
- Refinement of Macromolecular Structures by the Maximum-Likelihood MethodActa Crystallographica Section D-Biological Crystallography, 1997
- [20] Processing of X-ray diffraction data collected in oscillation modePublished by Elsevier ,1997
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D-Biological Crystallography, 1994
- Shape Complementarity at Protein/Protein InterfacesJournal of Molecular Biology, 1993